本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cellectar Biosciences Inc.

2.31
-0.0600-2.53%
盤後2.310.00000.00%19:50 EDT
成交量:3.84萬
成交額:9.02萬
市值:2,183.44萬
市盈率:-1.05
高:2.40
開:2.35
低:2.31
收:2.37
52周最高:6.52
52周最低:2.20
股本:945.21萬
流通股本:900.82萬
量比:1.02
換手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-2.2100
每股收益(LYR):-8.3544
淨資產收益率:-119.57%
總資產收益率:-58.44%
市淨率:0.73
市盈率(LYR):-0.28

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/10

重要事件披露

Form 8-K - Current report
2026/06/05

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/29

SEC問詢函

Form CORRESP - Correspondence
2026/05/29

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/05/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/30

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/03/04

重要事件披露

Form 8-K - Current report